Anest. intenziv. Med. 1998;9(6):238-240

Ondansetron in the prevention of postoperative nausea and vomitingArticles

P. Kothaj1, M. Novotný2, M. Onderčanin3, J. Příborský5, J. Vlček6, F. Vyhnánek7
1 Chirurgické oddělení nemocnice F. D. Roosevelta, Banská Bystrica
2 ARO, NMP Malvazinky, Praha 5
3 ARO, NsP, Galanta
4 Glaxo Wellcome s. r. o., Praha 9
5 Chirurgická klinika, FN Ostrava-Zábřeh
6 Klinika anesteziologie a resuscitace, FN Olomouc
7 Chirurgick

Ondansetron in the prevention of postoperative nausea and vomiting (PONV) in patients with general anaesthesia undergoing elective abdominal surgery was evaluated in randomised, double blind, placebo controlled, multicenter, parallel group study. Based on the results, we can conclude that ondansetron in dose 4 mg i.v. is effective in the prevention of postoperative hausea and vomiting. Number of emetic episodes was in ondansetron group statistically significantly lower and no nausea was observed in larger number of patients. No significant increase of adverse events was observed in ondansetron group vs. placebo.

Keywords: ondansetron; postoperative nausea and vomiting; double blind study

Published: December 1, 1998  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kothaj P, Novotný M, Onderčanin M, Příborský J, Vlček J, Vyhnánek F. Ondansetron in the prevention of postoperative nausea and vomiting. Anest. intenziv. Med. 1998;9(6):238-240.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)

    • Return to the content


    Anesteziologie a intenzivní medicína

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.